Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases
Codjia, P., Ayrignac, X., Carra-Dalliere, C., Cohen, M., Charif, M., Lippi, A., Collongues, N., Corti, L., De Seze, J., Lebrun, C., et al. (2019). Multiple Sclerosis and Related Disorders (28). p.109–116

Multiple sclerosis registries in Europe – An updated mapping survey
Glaser, A., Stahmann, A., Meissner, T., Flachenecker, P., Horáková, D., Zaratin, P., Brichetto, G., Pugliatti, M., Rienhoff, O., Vukusic, S., et al. (2019). Multiple Sclerosis and Related Disorders (27). p.171–178

Automatic segmentation of the spinal cord and intramedullary multiple sclerosis lesions with convolutional neural networks
Gros, C., De Leener, B., Badji, A., Maranzano, J., Eden, D., Dupont, S.M., Talbott, J., Zhuoquiong, R., Liu, Y., Granberg, T., et al. (2019). NeuroImage (184). p.901–915

First clinical inflammatory demyelinating events of the central nervous system in a population aged over 70 years: a multicentre study
Ouallet, D.J.-C. (2018a). Multiple Sclerosis and Related Disorders

Observatoire Français de la Sclérose en Plaques (OFSEP): A unique multimodal nationwide MS registry in France
Vukusic, S., Casey, R., Rollot, F., Brochet, B., Pelletier, J., Laplaud, D.-A., De Sèze, J., Cotton, F., Moreau, T., Stankoff, B., et al. (2018). Mult Scler p.1352458518815602

Indications de l’autogreffe dans la sclérose en plaques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) en lien avec la Société francophone de la sclérose en plaques
Zephir, H., Puyade, M., Gueguen, A., Michel, L., Terriou, L., Dive, D., Laureys, G., Mathey, G., Labauge, P., Marjanovic, Z., et al. (2018). Bulletin Du Cancer

Human Induced Pluripotent Stem Cell-Derived Astrocytes Are Differentially Activated by Multiple Sclerosis-Associated Cytokines
Perriot, S., Mathias, A., Perriard, G., Canales, M., Jonkmans, N., Merienne, N., Meunier, C., El Kassar, L., Perrier, A.L., Laplaud, D.-A., et al. (2018). Stem Cell Reports (11). p.1199–1210

Diversité des prises en charge des patients atteints de sclérose en plaques entre régions françaises
Blein, C., Chamoux, C., Reynaud, D., and Lepage, V. (2018). Revue d’Épidémiologie et de Santé Publique (66). p.385–394

Evidence of axonal damage in cerebellar peduncles without T2-lesions in multiple sclerosis
Hannoun, S., Kocevar, G., Durand-Dubief, F., Stamile, C., Naji, A., Cotton, F., Cavallari, M., Guttmann, C.R.G., and Sappey-Marinier, D. (2018a). European Journal of Radiology (108). p.114–119

Case Report: Acute Transverse Myelitis after Zika Virus Infection
Neri, V.C., Xavier, M.F., Barros, P.O., Melo Bento, C., Marignier, R., and Papais Alvarenga, R. (2018). Am. J. Trop. Med. Hyg.

Outcomes and treatment management of a French cohort suffering from multiple sclerosis: A retrospective epidemiological study
Defer, G., de Seze, J., Bouee, S., Courouve, L., Longin, J., Payet, M., Deleglise, A.S.J., and study group (2018). Mult Scler Relat Disord (25). p.276–281

Objective Evaluation of Multiple Sclerosis Lesion Segmentation using a Data Management and Processing Infrastructure
Commowick, O., Istace, A., Kain, M., Laurent, B., Leray, F., Simon, M., Pop, S.C., Girard, P., Améli, R., Ferré, J.-C., et al. (2018). Sci Rep (8). p.13650

“Myelitis migrans”: A rare cause of treatable myelitis
Jaulent, P., Pegat, A., Grosset-Janin, C., Durand-Dubief, F., Vukusic, S., and Marignier, R. (2018a). Rev. Neurol. (Paris)

Weekly enhanced T1-weighted MRI with Gadobutrol injections in MS patients: Is there a signal intensity increase in the dentate nucleus and the globus pallidus?
Jaulent, P., Hannoun, S., Kocevar, G., Rollot, F., Durand-Dubief, F., Vukusic, S., Brisset, J.-C., Sappey-Marinier, D., and Cotton, F. (2018b). Eur J Radiol (105). p.204–208

Unusual neurologic presentation of aseptic abscesses syndrome
Nicolas, P., Guerrier, O., Benoit, A., Durand-Dubief, F., Raverot, G., Debarbieux, S., Delteil, C., Vasiljevic, A., Jouanneau, E., Cotton, F., et al. (2018). Neurol Neuroimmunol Neuroinflamm (5). p.e469

Organization of care for multiple sclerosis in France
Derache, N., Dufay, A., and Lebarbey, C. (2018). Revue Neurologique (174). p.475–479

Organization of healthcare in multiple sclerosis
Gignoux, L. (2018). Revue Neurologique (174). p.471–474

Efficacité comparée du Teriflunomide et du Dimethyl-Fumarate : une étude observationnelle française multicentrique
Laplaud, D.-A., Barbin, L., Casey, R., Debouverie, M., Vukusic, S., Labauge, P., Brassat, D., Wiertlewski, S., De Seze, J., Edan, G., et al. (2018). Revue d’Épidémiologie et de Santé Publique (66). p.S201

Demyelinating diseases
Lebrun, C., and de Seze, J. (2018). Revue Neurologique (174). p.355

Conventional and advanced MRI in multiple sclerosis
Louapre, C. (2018). Revue Neurologique (174). p.391–397

Efficacy of rituximab in refractory RRMS
Durozard, P., Maarouf, A., Boutiere, C., Ruet, A., Brochet, B., Vukusic, S., Carra-Dalliere, C., Labauge, P., Mathey, G., Debouverie, M., et al. (2018). Mult. Scler.

Diagnostic value of 3DFLAIR in clinical practice for the detection of infratentorial lesions in multiple sclerosis in regard to dual echo T2 sequences
Hannoun, S., Heidelberg, D., Hourani, R., Nguyen, T.T.T., Brisset, J.-C., Grand, S., Kremer, S., Bonneville, F., Guttmann, C.R.G., Dousset, V., et al. (2018b). European Journal of Radiology (102). p.146–151

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study
Cobo-Calvo, A., Ruiz, A., Maillart, E., Audoin, B., Zephir, H., Bourre, B., Ciron, J., Collongues, N., Brassat, D., Cotton, F., et al. (2018). Neurology

Oligoclonal Bands in Spinal Fluid Improve the Specificity of Different MRI Criteria for Dissemination in Space to Predict a First Clinical Event in Children with the Radiologically Isolated Syndrome (S51.002)
Makhani, N., Lebrun, C., Siva, A., Narula, S., Wassmer, E., Brenton, J.N., Brassat, D., Carra-Dalliere, C., Seze, J.D., Dubief, F.D., et al. (2018). Neurology (90). p.S51.002

Efficacité et sécurité d’emploi de l’alemtuzumab à 2 ans : retour sur 150 patients français
Ayrignac, X., De Seze, J., Vukusic, S., Brassat, D., Laplaud, D., Lebrun-Frénay, C., and Labauge, P. (2018). Revue Neurologique (174). p.S155

Formes atypiques de sclérose en plaques et autres affections inflammatoires démyélinisantes idiopathiques du système nerveux central : étude nationale sur 88 cas
Codjia, P., Ayrignac, X., Carra-Dallière, C., Durand-Dubief, F., De Seze, J., Lebrun-Frenay, C., and Labauge, P. (2018). Revue Neurologique (174). p.S100–S101

Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Hacohen, Y., Wong, Y.Y., Lechner, C., Jurynczyk, M., Wright, S., Konuskan, B., Kalser, J., Poulat, A.L., Maurey, H., Ganelin-Cohen, E., et al. (2018). JAMA Neurol (75). p.478–487

Controverse : les traitements de fond modifient-ils le passage en forme secondairement progressive ? Synthèse
Ouallet, J.-C. (2018b). Revue Neurologique (174). p.S180–S181

Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study
Cabre, P., Mejdoubi, M., Jeannin, S., Merle, H., Plumelle, Y., Cavillon, G., Smadja, D., Marignier, R., and Francophone Society of Multiple Sclerosis and OFSEP investigators (2018). J. Neurol. (265). p.917–925

Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders
Ciron, J., Audoin, B., Bourre, B., Brassat, D., Durand-Dubief, F., Laplaud, D., Maillart, E., Papeix, C., Vukusic, S., Zephir, H., et al. (2018). Revue Neurologique (174). p.255—264

The first MICCAI challenge on PET tumor segmentation
Hatt, M., Laurent, B., Ouahabi, A., Fayad, H., Tan, S., Li, L., Lu, W., Jaouen, V., Tauber, C., Czakon, J., et al. (2018). Medical Image Analysis (44). p.177–195

Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS
Lavie, C., Rollot, F., Durand-Dubief, F., Marignier, R., Ionescu, I., Casey, R., Moreau, T., Tourniaire, P., Hutchinson, M., D’Hooghe, M.B., et al. (2018). Multiple Sclerosis Journal (0).

Socio-economic status influences access to second-line disease modifying treatment in Relapsing Remitting Multiple Sclerosis patients
Calocer, F., Dejardin, O., Droulon, K., Launoy, G., and Defer, G. (2018). PLoS ONE (13). p.e0191646

Caractéristique de la cohorte française des syndromes radiologiques isolés (RIS)
Christine Lebrun-Frénay, R., Céline Callier, Patrick Vermersch, Caroline Papeix, Emmanuelle Le Page, Françoise Durand-Dubief, Pierre Labauge, OFSEP, SFSEP (2018). Revue Neurologique (5961). p.S2–S200

Quelle utilisation des traitements de fond chez des patients ayant une SEP rémittente en France sur la période 1990–2017 ? Éléments de réponse à partir des données de l’Ofsep
Leray, E., Rollot, F., Casey, R., Roux, J., De Seze, J., Laplaud, D., and Vukusic, S. (2018). Revue Neurologique (5961). p.S2–S200

Should we broaden indications for anti-JCV antibody tests in multiple sclerosis patients? Comments. Anti-JCV antibody index in multiple sclerosis care
Stankoff, B. (2017). Revue Neurologique (173). p.616–618

Radiologically isolated syndrome in children: Clinical and radiologic outcomes
Makhani, N., Lebrun, C., Siva, A., Brassat, D., Carra Dallière, C., de Seze, J., Du, W., Durand Dubief, F., Kantarci, O., Langille, M., et al. (2017a). Neurol Neuroimmunol Neuroinflamm (4). p.e395

MOG antibody-related disorders: common features and uncommon presentations
Cobo-Calvo, Á., Ruiz, A., D’Indy, H., Poulat, A.-L., Carneiro, M., Philippe, N., Durand-Dubief, F., Deiva, K., Vukusic, S., Desportes, V., et al. (2017). J. Neurol. (264). p.1945–1955

Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders
Montcuquet, A., Collongues, N., Papeix, C., Zephir, H., Audoin, B., Laplaud, D., Bourre, B., Brochet, B., Camdessanche, J.-P., Labauge, P., et al. (2017). Mult. Scler. (23). p.1377–1384

Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder
Asgari, N., Flanagan, E.P., Fujihara, K., Kim, H.J., Skejoe, H.P., Wuerfel, J., Kuroda, H., Kim, S.H., Maillart, E., Marignier, R., et al. (2017). Neurol Neuroimmunol Neuroinflamm (4). p.e343

Expansion of IL-6+ Th17-like cells expressing TLRs correlates with microbial translocation and neurological disabilities in NMOSD patients
Barros, P.O., Dias, A.S.O., Kasahara, T.M., Ornelas, A.M.M., Aguiar, R.S., Leon, S.A., Ruiz, A., Marignier, R., Araújo, A.C.R.A., Alvarenga, R., et al. (2017). J. Neuroimmunol. (307). p.82–90

An excessive risk of suicide may no longer be a reality for multiple sclerosis patients
Kalson-Ray, S., Edan, G., and Leray, E. (2017). Mult Scler (23). p.864–871

Multiple sclerosis broke my heart
Androdias, G., Bernard, E., Biotti, D., Collongues, N., Durand-Dubief, F., Pique, J., Sanchez, I., Delmas, C., Ninet, J., Marignier, R., et al. (2017). Ann. Neurol. (81). p.754–758

Comparison of MRI Dissemination in Space Criteria for Predicting a First Clinical Event in Children with the Radiologically Isolated Syndrome (S2.001)
Makhani, N., Lebrun, C., Siva, A., Narula, S., Wassmer, E., Brenton, J.N., Dalliere, C.C., Seze, J.D., Dubief, F.D., Langille, M., et al. (2017b). Neurology (88). p.S2.001

Neuromielite ottica acuta (malattia di Devic)
Nicolas, P., and Marignier, R. (2017). EMC - Neurologia (17). p.1–13

Can we discontinue disease-modifying treatments in multiple sclerosis patients? No
Papeix, C. (2017). Revue Neurologique (173). p.41–43

L’OFSEP : du soin à la recherche, améliorer nos connaissances sur la sclérose en plaques
Debard, N., Casey, R., Vukusic, S., and investigateurs de l’OFSEP (2017). La Lettre Du Neurologue

Neuromyelitis optica and neuromyelitis optica spectrum disorders
Marignier, R., Cobo Calvo, A., and Vukusic, S. (2017). Curr. Opin. Neurol. (30). p.208–215

Risk of relapse after natalizumab withdrawal: Results from the French TYSEDMUS cohort
Papeix, C., Vukusic, S., Casey, R., Debard, N., Stankoff, B., Mrejen, S., Uhry, Z., Van Ganse, E., Castot, A., Clanet, M., et al. (2016). Neurology - Neuroimmunology & Neuroinflammation (3). p.e297

History of multiple sclerosis in 2 successive pregnancies: A French and Italian cohort
Benoit, A., Durand-Dubief, F., Amato, M.-P., Portaccio, E., Casey, R., Roggerone, S., Androdias, G., Gignoux, L., Ionescu, I., Marrosu, M.-G., et al. (2016). Neurology (87). p.1360–1367

Observatoire français de la sclérose en plaques, point sur l’imagerie en 2016
Cotton, F. (2016). Journal of Neuroradiology (43). p.70–71

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study
Barbin, L., Rousseau, C., Jousset, N., Casey, R., Debouverie, M., Vukusic, S., De Sèze, J., Brassat, D., Wiertlewski, S., Brochet, B., et al. (2016). Neurology (86). p.771–778

Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome
Kantarci, O.H., Lebrun, C., Siva, A., Keegan, M.B., Azevedo, C.J., Inglese, M., Tintoré, M., Newton, B.D., Durand-Dubief, F., Amato, M.P., et al. (2016). Ann. Neurol. (79). p.288–294

Efficacy of rituximab in refractory neuromyelitis optica
Collongues, N., Brassat, D., Maillart, E., Labauge, P., Ouallet, J.C., Carra-Dalliere, C., Moreau, T., Bourre, B., Papeix, C., Brochet, B., et al. (2016). Mult. Scler. (22). p.955–959

Suivi en imagerie par résonance magnétique des patients avec une sclérose en plaques : comment ?
Cotton, F. (2016). Pratique Neurologique - FMC (7). p.153–158

Multiple sclerosis lesion formation and early evolution revisited: A weekly high-resolution magnetic resonance imaging study
Guttmann, C.R., Rousset, M., Roch, J.A., Hannoun, S., Durand-Dubief, F., Belaroussi, B., Cavallari, M., Rabilloud, M., Sappey-Marinier, D., Vukusic, S., et al. (2016). Mult. Scler. (22). p.761–769

Graph Theory-Based Brain Connectivity for Automatic Classification of Multiple Sclerosis Clinical Courses
Kocevar, G., Stamile, C., Hannoun, S., Cotton, F., Vukusic, S., Durand-Dubief, F., and Sappey-Marinier, D. (2016). Front Neurosci (10). p.478

Analgésie locorégionale et risque de poussée du post-partum chez les femmes ayant une sclérose en plaques active au cours de la grossesse
Lavie, C., Rollot, F., Durand-Dubief, F., Marignier, R., Ionescu, I., Frangoulis, B., and Vukusic, S. (2016). Revue Neurologique (172). p.A96–A97

Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid
Marignier, R., Ruiz, A., Cavagna, S., Nicole, A., Watrin, C., Touret, M., Parrot, S., Malleret, G., Peyron, C., Benetollo, C., et al. (2016). J Neuroinflammation (13). p.111

Geographical Heterogeneity of Multiple Sclerosis Prevalence in France
Pivot, D., Debouverie, M., Grzebyk, M., Brassat, D., Clanet, M., Clavelou, P., Confavreux, C., Edan, G., Leray, E., Moreau, T., et al. (2016). PLoS ONE (11). p.e0167556

A Sensitive and Automatic White Matter Fiber Tracts Model for Longitudinal Analysis of Diffusion Tensor Images in Multiple Sclerosis
Stamile, C., Kocevar, G., Cotton, F., Durand-Dubief, F., Hannoun, S., Frindel, C., Guttmann, C.R.G., Rousseau, D., and Sappey-Marinier, D. (2016). PLoS ONE (11). p.e0156405

Neuromyelitis optica: a positive appraisal of seronegative cases
Bernard-Valnet, R., Liblau, R.S., Vukusic, S., and Marignier, R. (2015). Eur. J. Neurol. (22). p.1511–1518, e82-83

A longitudinal model for variations detection in white matter fiber-bundles
Stamile, C., Kocevar, G., Cotton, F., Hannoun, S., Durand-Dubief, F., Frindel, C., Rousseau, D., and Sappey-Marinier, D. (2015). A longitudinal model for variations detection in white matter fiber-bundles. In 2015 International Conference on Systems, Signals and Image Processing (IWSSIP), pp. 57–60

Does cerebrospinal fluid analysis add predictive value to magnetic resonance imaging for long term irreversible disability in patients with early multiple sclerosis?
Moroso, A., Deloire, M.S.A., Ruet, A., Ouallet, J.-C., Casey, R., and Brochet, B. (2015). Journal of the Neurological Sciences (354). p.51–55

OFSEP, a nationwide cohort of people with multiple sclerosis: Consensus minimal MRI protocol
Cotton, F., Kremer, S., Hannoun, S., Vukusic, S., Dousset, V., and Imaging Working Group of the Observatoire Français de la Sclérose en Plaques (2015a). J Neuroradiol (42). p.133–140

Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis
Vukusic, S., Durand-Dubief, F., Benoit, A., Marignier, R., Frangoulis, B., and Confavreux, C. (2015). Mult. Scler. (21). p.953–955

[Evolution of Devic’s neuromyelitis optica spectrum disorders]
Bernard-Valnet, R., and Marignier, R. (2015). Presse Med (44). p.401–410

Weekly multimodal MRI follow-up of two multiple sclerosis active lesions presenting a transient decrease in ADC
Hannoun, S., Roch, J.-A., Durand-Dubief, F., Vukusic, S., Sappey-Marinier, D., Guttmann, C.R.G., and Cotton, F. (2015). Brain Behav (5). p.e00307

L’Observatoire français de la sclérose en plaques (OFSEP): établissement d’un protocole commun minimum dans la sclérose en plaques
Cotton, F., Hannoun, S., Kremer, S., Guillaumont, J., and Dousset, V. (2015b). Revue Neurologique (171). p.A65–A66

Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study
Leray, E., Vukusic, S., Debouverie, M., Clanet, M., Brochet, B., de Sèze, J., Zéphir, H., Defer, G., Lebrun-Frenay, C., Moreau, T., et al. (2015). PLoS ONE (10). p.e0132033

Microstructural changes in the striatum and their impact on motor and neuropsychological performance in patients with multiple sclerosis
Cavallari, M., Ceccarelli, A., Wang, G.-Y., Moscufo, N., Hannoun, S., Matulis, C.R., Jackson, J.S., Glanz, B.I., Bakshi, R., Neema, M., et al. (2014). PLoS ONE (9). p.e101199

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset
Collongues, N., Marignier, R., Jacob, A., Leite, M.I., Siva, A., Paul, F., Zephir, H., Akman-Demir, G., Elsone, L., Jarius, S., et al. (2014). Mult. Scler. (20). p.1086–1094

Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity
Marignier, R., Bernard-Valnet, R., Giraudon, P., Collongues, N., Papeix, C., Zéphir, H., Cavillon, G., Rogemond, V., Casey, R., Frangoulis, B., et al. (2013). Neurology (80). p.2194–2200

Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study
Cabre, P., Olindo, S., Marignier, R., Jeannin, S., Merle, H., Smadja, D., and Aegis of French National Observatory of Multiple Sclerosis (2013). J. Neurol. Neurosurg. Psychiatry (84). p.511–516

TYSEDMUS : suivi observationnel prospectif des patients atteints de sclérose en plaques et traités par TYSABRI® (natalizumab) dans les bases des données EDMUS en France : données finales à cinq ans
Passante, N. (2013). Revue Neurologique (169). p.A227

P296 Double seronegative longitudinally extensive transverse myelitis: preliminary study on 17 patients. E. Maillart, Paris, FR

P301 Myelin oligodendrocyte glycoprotein antibodies predict a favourable outcome in neuromyelitis optica related disorders. A. Cobo-Calvo, Lyon, FR

P302 Myelin oligodendrocyte glycoprotein antibodies spectrum disorder: clinical features and prognostic factors in a cohort of 150 adult patients. A. Cobo-Calvo, Lyon, FR

P303 Prognostic factor for therapeutic response of attacks in anti-AQP4, anti-MOG seropositive and NMO seronegative patients. N. Collongues, Strasbourg, FR

P323 Characteristics of radiologically isolated syndrome (RIS) national French cohort. C. Lebrun-Frenay, Nice, FR

P335 Observatoire Français de la Sclérose en Plaques (OFSEP): a powerful epidemiological tool. R. Casey, Lyon, FR

P738 Big Multiple Sclerosis Data network: data sharing among five large MS registries. P. Iaffaldano, Bari, IT

P1149 Efficacy and safety of alemtuzumab in 150 patients with active relapsing-remitting MS: two-year follow-up in France. X. Ayrignac, Montpellier, FR

P1154 Efficacy of rituximab as a rescue therapy after the failure of second line treatment in relapsing remitting multiple sclerosis: a retrospective observational monocenter study. P. Durozard, Marseille, FR

P1237 Disease-modifying therapies use in primary progressive multiple sclerosis patients in France: data from the OFSEP cohort over the 1996 - 2017 period. E. Leray, Rennes, FR

P1854 Big Multiple Sclerosis Data Network: impact of early treatment on long term disability accumulation in relapsing remitting multiple sclerosis patients. P. Iaffaldano, Bari, IT